Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gender decrease » teer decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gender decrease » teer decrease (Expand Search)
-
2421
-
2422
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2423
-
2424
-
2425
-
2426
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2427
-
2428
-
2429
-
2430
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2431
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2432
-
2433
-
2434
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2435
-
2436
-
2437
-
2438
-
2439
-
2440